Acumen Pharmaceuticals
3 clinical trials · Sponsor
◉ Watch Acumen Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants (NCT06511570) | Acumen Pharmaceuticals | 2024-06-25 |
| A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD) (NCT06335173) | Acumen Pharmaceuticals | 2024-02-29 |
| A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD (NCT04931459) | Acumen Pharmaceuticals | 2021-06-21 |
Track Acumen Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.